S&P 500   3,669.94 (+1.33%)
DOW   29,907.32 (+0.91%)
QQQ   304.09 (+1.49%)
AAPL   122.77 (+3.12%)
MSFT   215.64 (+0.73%)
FB   288.11 (+4.02%)
GOOGL   1,810.40 (+3.19%)
AMZN   3,233.21 (+2.06%)
TSLA   580.92 (+2.35%)
NVDA   537.00 (+0.18%)
BABA   263.79 (+0.16%)
CGC   28.16 (-2.22%)
GE   10.35 (+1.67%)
MU   67.70 (+5.63%)
AMD   92.73 (+0.08%)
T   28.83 (+0.28%)
NIO   47.55 (-5.90%)
F   9.32 (+2.64%)
ACB   10.90 (-6.68%)
NFLX   504.79 (+2.87%)
BA   217.35 (+3.15%)
GILD   61.54 (+1.43%)
DIS   150.75 (+1.85%)
S&P 500   3,669.94 (+1.33%)
DOW   29,907.32 (+0.91%)
QQQ   304.09 (+1.49%)
AAPL   122.77 (+3.12%)
MSFT   215.64 (+0.73%)
FB   288.11 (+4.02%)
GOOGL   1,810.40 (+3.19%)
AMZN   3,233.21 (+2.06%)
TSLA   580.92 (+2.35%)
NVDA   537.00 (+0.18%)
BABA   263.79 (+0.16%)
CGC   28.16 (-2.22%)
GE   10.35 (+1.67%)
MU   67.70 (+5.63%)
AMD   92.73 (+0.08%)
T   28.83 (+0.28%)
NIO   47.55 (-5.90%)
F   9.32 (+2.64%)
ACB   10.90 (-6.68%)
NFLX   504.79 (+2.87%)
BA   217.35 (+3.15%)
GILD   61.54 (+1.43%)
DIS   150.75 (+1.85%)
S&P 500   3,669.94 (+1.33%)
DOW   29,907.32 (+0.91%)
QQQ   304.09 (+1.49%)
AAPL   122.77 (+3.12%)
MSFT   215.64 (+0.73%)
FB   288.11 (+4.02%)
GOOGL   1,810.40 (+3.19%)
AMZN   3,233.21 (+2.06%)
TSLA   580.92 (+2.35%)
NVDA   537.00 (+0.18%)
BABA   263.79 (+0.16%)
CGC   28.16 (-2.22%)
GE   10.35 (+1.67%)
MU   67.70 (+5.63%)
AMD   92.73 (+0.08%)
T   28.83 (+0.28%)
NIO   47.55 (-5.90%)
F   9.32 (+2.64%)
ACB   10.90 (-6.68%)
NFLX   504.79 (+2.87%)
BA   217.35 (+3.15%)
GILD   61.54 (+1.43%)
DIS   150.75 (+1.85%)
S&P 500   3,669.94 (+1.33%)
DOW   29,907.32 (+0.91%)
QQQ   304.09 (+1.49%)
AAPL   122.77 (+3.12%)
MSFT   215.64 (+0.73%)
FB   288.11 (+4.02%)
GOOGL   1,810.40 (+3.19%)
AMZN   3,233.21 (+2.06%)
TSLA   580.92 (+2.35%)
NVDA   537.00 (+0.18%)
BABA   263.79 (+0.16%)
CGC   28.16 (-2.22%)
GE   10.35 (+1.67%)
MU   67.70 (+5.63%)
AMD   92.73 (+0.08%)
T   28.83 (+0.28%)
NIO   47.55 (-5.90%)
F   9.32 (+2.64%)
ACB   10.90 (-6.68%)
NFLX   504.79 (+2.87%)
BA   217.35 (+3.15%)
GILD   61.54 (+1.43%)
DIS   150.75 (+1.85%)
Log in
ASX:CSL

CSL Limited (CSL.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$307.61
MA: A$307.61
A$307.61
52-Week Range N/A
Volume869,289 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.95%
BetaN/A
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
CSL Limited (CSL.AX) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.8Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.10 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-3-93891911
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.15 billion
Book ValueA$14.38 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableOptionable

Receive CSL News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CSL Limited (CSL.AX) (ASX:CSL) Frequently Asked Questions

What stocks does MarketBeat like better than CSL Limited (CSL.AX)?

Wall Street analysts have given CSL Limited (CSL.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CSL Limited (CSL.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is CSL Limited (CSL.AX)'s next earnings date?

CSL Limited (CSL.AX) is scheduled to release its next quarterly earnings announcement on Friday, February 12th 2021.
View our earnings forecast for CSL Limited (CSL.AX)
.

How were CSL Limited (CSL.AX)'s earnings last quarter?

CSL Limited (CSL.AX) (ASX:CSL) announced its quarterly earnings data on Wednesday, August, 14th. The company reported $4.24 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $4.22 by $0.01.
View CSL Limited (CSL.AX)'s earnings history
.

How often does CSL Limited (CSL.AX) pay dividends? What is the dividend yield for CSL Limited (CSL.AX)?

CSL Limited (CSL.AX) announced a Final dividend on Thursday, August 20th. Shareholders of record on Friday, October 9th will be paid a dividend of 1.481 per share on Friday, October 9th. This represents a dividend yield of 0.49%. The ex-dividend date is Thursday, September 10th. This is an increase from CSL Limited (CSL.AX)'s previous Final dividend of A$1.48.
View CSL Limited (CSL.AX)'s dividend history
.

Who are some of CSL Limited (CSL.AX)'s key competitors?

What other stocks do shareholders of CSL Limited (CSL.AX) own?

Who are CSL Limited (CSL.AX)'s key executives?

CSL Limited (CSL.AX)'s management team includes the following people:
  • Mr. Paul R. Perreault B.A., MD, CEO & Exec. Director (Age 63, Pay $4.23M)
  • Mr. David Mark Lamont C.A., ACA, BCom, Chief Financial Officer (Age 54, Pay $1.84M)
  • Dr. Paul F. McKenzie, Chief Operating Officer (Age 54, Pay $2.74M)
  • Dr. Robert Andrew Cuthbertson A.O., BMedSci, MBBS, Ph.D., FTSE, FAHMS, AO, Sr. Adviser & Exec. Director (Age 65, Pay $1.48M)
  • Ms. Joy Carolyn Linton BComm, Grad Dip AFI, GAICD, Chief Financial Officer (Age 55)
  • Mr. Mark Dehring, Head of Investor Relations
  • Mr. Gregory Boss B.S., BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel (Age 59)
  • Christina Hickie, Sr. Mang. of Communications
  • Ms. Elizabeth Walker B.A., M.S., Exec. VP & Chief HR Officer (Age 50)
  • Dr. Karen Etchberger, Exec. VP of Quality & Bus. Services (Age 62)

What is CSL Limited (CSL.AX)'s stock symbol?

CSL Limited (CSL.AX) trades on the ASX under the ticker symbol "CSL."

How big of a company is CSL Limited (CSL.AX)?

CSL Limited (CSL.AX) has a market capitalization of $0.00 and generates $9.15 billion in revenue each year. CSL Limited (CSL.AX) employs 27,000 workers across the globe.

What is CSL Limited (CSL.AX)'s official website?

The official website for CSL Limited (CSL.AX) is www.csl.com.au.

How can I contact CSL Limited (CSL.AX)?

CSL Limited (CSL.AX)'s mailing address is 45 Poplar Road,, Parkville, MELBOURNE, VIC 3052, Australia. The company can be reached via phone at +61-3-93891911.

This page was last updated on 12/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.